Biopharma caught in the crosshairs of U.S.-China trade tussle by Angus Liu Wednesday, April 4, 2018 A long list of biopharma materials and medical devices from China have become targets of additional U.S. tariffs.
J&J execs score hefty retention bonuses as Gorsky nabs $29M by Tracy Staton Thursday, March 29, 2018 That J&J chief Alex Gorsky got a raise in 2017 isn't all that surprising. But J&J's pay figures aren't boring: Two EVPs nabbed $8M-plus bonuses.
J&J takes $14B hit on the way to 'immediate' tax reform windfall by Carly Helfand Tuesday, January 23, 2018 Johnson & Johnson may have posted a fourth-quarter loss, but it’s just a step toward billions of dollars in cash coming home.
J&J chief’s pharma-tech vision is pretty, but it’s not reality by Carly Helfand Wednesday, January 10, 2018 Pharma could very well get caught with its tail between its legs when a true tech player comes in to disrupt the market, experts say.
Trump ends, J&J CEO leaves manufacturing council by Eric Sagonowsky Wednesday, August 16, 2017 J&J chief Alex Gorsky bailed out of President Donald Trump's manufacturing council just as the president announced he would shut it down.
Don't count on more pharmas defying Trump after Frazier's exit by Eric Sagonowsky Tuesday, August 15, 2017 Top drugmakers and pharma's industry kept mum in the wake of Merck CEO Ken Frazier's decision to exit a Trump manufacturing panel.
Cyndi Lauper stars in Novartis' latest Cosentyx spot by Carly Helfand Friday, July 21, 2017 Cyndi Lauper is back to star in another round of Novartis’ Cosentyx marketing. The '80s pop icon appears with two real-life patients in a new TV spot.
J&J CEO says real healthcare reform takes time—and cooperation by Eric Sagonowsky Wednesday, June 28, 2017 One prominent pharma CEO figures overhauling healthcare won't take a few weeks of work. Think years—even decades.
